Medicine
Saxenda 18 mg/3 mL injection
Saxenda 18 mg/3 mL injection is a prescription medicine containing Liraglutide for subcutaneous use, marketed by Novo Nordisk Pharmaceutical Industries, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Prior to first use, SAXENDA should be stored in a refrigerator between 36ºF to…
Key facts
- Active ingredient (INN)
- Liraglutide
- Brand
- Saxenda
- Strength
- 18 mg/3 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 5 syringes of 3 mL, 1 syringe of 3 mL and 1 more
- Marketing authorisation holder
- Novo Nordisk Pharmaceutical Industries
- Manufacturers
- Novo Nordisk Pharmaceutical IndustriesA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Prior to first use, SAXENDA should be stored in a refrigerator between 36ºF to 46ºF (2ºC to 8ºC). Do not store in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze SAXENDA and do not use SAXENDA if it has been frozen.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BJ02 Liraglutide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 December 2014
- Identifiers
- RxCUI 1598268, 2735350DailyMed set ID 7b11f6ac-4c27-4748-9e65-22d4cf3adfb4, 3946d389-0926-4f77-a708-0acb8153b143NDC 50090-4257, 0169-2800Application NDA206321
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 syringe, plastic in 1 carton / 3 mL in 1 syringe, plastic | 0169-2800-15 | Novo Nordisk Pharmaceutical Industries | 19 January 2015 |
| 1 syringe, plastic in 1 carton / 3 mL in 1 syringe, plastic | 0169-2800-90 | Novo Nordisk Pharmaceutical Industries | 19 January 2015 |
| 1 syringe, plastic in 1 carton / 3 mL in 1 syringe, plastic | 0169-2800-97 | Novo Nordisk Pharmaceutical Industries | 19 January 2015 |
| 5 syringe, plastic in 1 carton / 3 mL in 1 syringe, plastic | 50090-4257-0 | A-S Medication Solutions | 9 April 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Liraglutide 18 mg/3 mL injection.
Clinical summary
Liraglutide is a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus, among other approved uses. MedsAcross supplies Liraglutide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LiraglutideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Liraglutide prescribing information (Teva Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Ablymico: European public assessment report (EPAR) · European Medicines Agency
- Liraglutide STADA: European public assessment report (EPAR) · European Medicines Agency
Need Saxenda 18 mg/3 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.